Variant · Snv
HLA-DRB1 NM_002124.4(HLA-DRB1):c.100+1G>C
CI-VAR-00338726Explore in graph →NM_002124.4:c.100+1G>CClinVar 3059066 rs201278923
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 3059066 | Likely benign | no assertion criteria provided | 0 | HLA-DRB1-related disorder; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Colon adenocarcinoma; Colorectal cancer; Acute myeloid leukemia; Uterine corpus endometrial carcinoma; Hepatocellular carcinoma; Nonpapillary renal cell carcinoma; Malignant tumor of esophagus; Lung cancer; Familial cancer of breast | germline | 2 | Dec 17, 2020 | clinvar |